老虎證券
Invest
Pricing
Rewards
Support
About
Quotes
TigerAI
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Clinuvel Pharmaceuticals Ltd.
5.86
-0.0400
-0.68%
盤後：
5.86
0.0000
0.00%
16:10 EDT
成交量：
4,477
成交額：
2.65萬
市值：
2.96億
市盈率：
12.68
高：
6.02
開：
6.01
低：
5.84
收：
5.90
52周最高：
8.92
52周最低：
5.80
股本：
5,042.79萬
流通股本：
4,387.83萬
量比：
0.25
換手率：
0.01%
股息：
0.04
股息率：
0.61%
每股收益(TTM):
0.4621
每股收益(LYR):
0.4621
淨資產收益率：
13.21%
總資產收益率：
8.94%
市淨率：
1.52
市盈率(LYR):
12.68
資料載入中...
總覽
公司
新聞資訊
公告
公司資料
公司名字：
Clinuvel Pharmaceuticals Ltd.
交易所：
NASDAQ
成立時間：
1999
員工人數：
16
公司地址：
535 Bourke Street,Level 22,Melbourne,Victoria,Australia
官網：
http://www.clinuvel.com
郵編：
3000
電話：
61 3 9660 4900
傳真：
61 3 9660 4999
簡介：
Clinuvel Pharmaceuticals Limited是一家於1999年根據澳大利亞法律註冊成立的股份有限公司。該公司是一家全球性專業製藥集團，專註於為患有遺傳性、代謝性、全身性和危及生命的急性疾病的患者開發治療方法並將其商業化，以及為專門人群開發醫療保健解決方案，業務遍及歐洲、新加坡和美國。
董事
名稱
職位
Guy van Dievoet
Non-Executive Director
Jeffrey Rosenfeld
Chair of the Board and Non-Executive Director
Karen Agersborg
Non-Executive Director
Matthew Pringle
Non-Executive Director
Pearl Grimes
Non-Executive Director
Susan Smith
Non-Executive Director
股東
名稱
職位
Philippe Wolgen
Chief Executive Officer and Managing Director
Lachlan Hay
Chief Operating Officer
Peter Vaughan
Chief Financial Officer
Dennis Wright
Chief Scientific Officer
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/CUVL/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"CUVL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CUVL\",,,,,undefined,":{"symbol":"CUVL","market":"US","secType":"STK","nameCN":"Clinuvel Pharmaceuticals Ltd.","latestPrice":5.86,"timestamp":1789675200000,"preClose":5.9,"halted":0,"volume":4477,"hourTrading":{"tag":"盘后","latestPrice":5.86,"preClose":5.86,"latestTime":"16:10 EDT","volume":3,"amount":17.58,"timestamp":1789675804667,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.006779661016949158,"floatShares":43878300,"shares":50427898,"eps":0.462123,"marketStatus":"未開盤","change":-0.04,"latestTime":"09-17 16:00:00 EDT","open":6.01,"high":6.02,"low":5.8424,"amount":26503,"amplitude":0.030102,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.462123,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789718400000},"marketStatusCode":0,"adr":0,"adrRate":1,"exchange":"NASDAQ","adjPreClose":5.9,"dividendRate":0.006114,"postHourTrading":{"tag":"盘后","latestPrice":5.86,"preClose":5.86,"latestTime":"16:10 EDT","volume":3,"amount":17.58,"timestamp":1789675804667,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.251046},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CUVL\",,,,,undefined,":{"symbol":"CUVL","floatShares":43878300,"roa":"8.94%","roe":"13.21%","lyrEps":0.462123,"volumeRatio":0.251046,"shares":50427898,"dividePrice":0.035624,"high":6.02,"amplitude":0.030102,"preClose":5.9,"low":5.8424,"week52Low":5.8,"pbRate":"1.52","psRate":"4.41","week52High":8.92,"institutionHeld":0,"latestPrice":5.86,"eps":0.462123,"divideRate":0.006079,"volume":4477,"delay":0,"ttmEps":0.462123,"open":6.01,"prevYearClose":8.48,"prevWeekClose":5.95,"prevMonthClose":5.95,"prevQuarterClose":7.3,"fiveDayClose":5.88,"twentyDayClose":7.15,"sixtyDayClose":7.1,"dividendPayoutRate":0.055654438728341596,"dividendFrequency":"A","dividendGrowthYears":0,"dividendGrowthRate":-0.12779744805932258,"fiveYearAvgDividendRate":0.004014656862745098},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CUVL\",params:#limit:5,,,undefined,":[{"date":"2026-09-08","symbol":"CUVL","amount":0.03582,"announcedDate":"2026-08-27","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-08","defaultRemindTime":1788874200000,"name":"Clinuvel Pharmaceuticals Ltd.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-28","payableDate":"2026-09-08","currency":"USD","dateTimestamp":1788840000000,"payDate":"2026-09-28"},{"date":"2026-08-27","symbol":"CUVL","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787817600000,"name":null,"time":"盤前","dateTimestamp":1787803200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CUVL\",market:\"US\",,,undefined,":[{"executeDate":"2026-09-08","recordDate":"2026-09-08","paymentDate":"2026-09-28","value":0.03582,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CUVL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.2857,"hold":0.4286,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2857,"analysts":7,"updateTime":1787889600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CUVL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CUVL","date":"2026-09-16","current":12.680607,"percent":0.1,"low":11.909356,"twenty":12.281058,"median":14.62941,"eighty":15.59024,"high":16.876512,"avg":14.250035,"sd":1.547186,"marketCap":292424258.2},"quantilePoints":[{"date":"2026-07-24","current":15.59024,"twenty":15.398074,"median":15.574742,"eighty":15.64603,"marketCap":353645627.74},{"date":"2026-07-31","current":14.040514,"twenty":14.675902,"median":15.311289,"eighty":15.580941,"marketCap":320255681.34},{"date":"2026-08-07","current":14.62941,"twenty":14.316365,"median":14.745639,"eighty":15.481759,"marketCap":334861674.87},{"date":"2026-08-14","current":14.79988,"twenty":14.434144,"median":14.861869,"eighty":15.354681,"marketCap":340007360.21},{"date":"2026-08-21","current":16.148141,"twenty":14.496133,"median":14.978098,"eighty":15.70182,"marketCap":374125095.76},{"date":"2026-08-28","current":12.593289,"twenty":14.434144,"median":15.047836,"eighty":16.017964,"marketCap":307239459.07},{"date":"2026-09-04","current":12.117509,"twenty":14.049812,"median":14.861869,"eighty":15.918781,"marketCap":295738193.85},{"date":"2026-09-11","current":11.95396,"twenty":12.340531,"median":14.761136,"eighty":15.75761,"marketCap":290763266.64},{"date":"2026-09-16","current":12.087773,"twenty":12.281058,"median":14.62941,"eighty":15.59024,"marketCap":292424258.2}],"updateTime":1789712237088},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":6117181,"yearFounded":1999,"employeeNum":16,"address":"535 Bourke Street,Level 22,Melbourne,Victoria,Australia","zipCode":"3000","officePhone":"61 3 9660 4900","officeFax":"61 3 9660 4999","fiscalYearEnd":"06-30"},"stockCompanyDetail":{"websiteUrl":"http://www.clinuvel.com","stockEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.1507},{"period":"3month","weight":-0.2038},{"period":"6month","weight":-0.1433},{"period":"1year","weight":-0.239},{"period":"ytd","weight":-0.309}],"compareEarnings":[{"period":"1week","weight":0.0063},{"period":"1month","weight":-0.0063},{"period":"3month","weight":0.0212},{"period":"6month","weight":0.1758},{"period":"1year","weight":0.1569},{"period":"ytd","weight":0.1183}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Clinuvel Pharmaceuticals Limited是一家於1999年根據澳大利亞法律註冊成立的股份有限公司。該公司是一家全球性專業製藥集團，專註於為患有遺傳性、代謝性、全身性和危及生命的急性疾病的患者開發治療方法並將其商業化，以及為專門人群開發醫療保健解決方案，業務遍及歐洲、新加坡和美國。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.016564},{"month":2,"riseRate":0.25,"avgChangeRate":-0.088904},{"month":3,"riseRate":0.375,"avgChangeRate":0.036975},{"month":4,"riseRate":0.625,"avgChangeRate":0.007121},{"month":5,"riseRate":0.555556,"avgChangeRate":0.057074},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.013615},{"month":7,"riseRate":0.555556,"avgChangeRate":0.025547},{"month":8,"riseRate":0.555556,"avgChangeRate":0.019073},{"month":9,"riseRate":0.444444,"avgChangeRate":0.028933},{"month":10,"riseRate":0.5,"avgChangeRate":-0.018995},{"month":11,"riseRate":0.5,"avgChangeRate":-0.022089},{"month":12,"riseRate":0.625,"avgChangeRate":0.039793}],"exchange":"NASDAQ","name":"Clinuvel Pharmaceuticals Ltd.","nameEN":"Clinuvel Pharmaceuticals Ltd.","securityTypeName":"存托凭证","adrRate":"1:1"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"CUVL\",market:\"US\",,,undefined,":{"directors":[{"name":"Guy van Dievoet","position":"Non-Executive Director"},{"name":"Jeffrey Rosenfeld","position":"Chair of the Board and Non-Executive Director"},{"name":"Karen Agersborg","position":"Non-Executive Director"},{"name":"Matthew Pringle","position":"Non-Executive Director"},{"name":"Pearl Grimes","position":"Non-Executive Director"},{"name":"Susan Smith","position":"Non-Executive Director"}],"executives":[{"name":"Philippe Wolgen","position":"Chief Executive Officer and Managing Director"},{"name":"Lachlan Hay","position":"Chief Operating Officer"},{"name":"Peter Vaughan","position":"Chief Financial Officer"},{"name":"Dennis Wright","position":"Chief Scientific Officer"}]}}}